Literature DB >> 26633779

Prion Diseases.

Michael D Geschwind.   

Abstract

PURPOSE OF REVIEW: This article presents an update on the clinical aspects of human prion disease, including the wide spectrum of their presentations. RECENT
FINDINGS: Prion diseases, a group of disorders caused by abnormally shaped proteins called prions, occur in sporadic (Jakob-Creutzfeldt disease), genetic (genetic Jakob-Creutzfeldt disease, Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia), and acquired (kuru, variant Jakob-Creutzfeldt disease, and iatrogenic Jakob-Creutzfeldt disease) forms. This article presents updated information on the clinical features and diagnostic methods for human prion diseases. New antemortem potential diagnostic tests based on amplifying prions in order to detect them are showing very high specificity. Understanding of the diversity of possible presentations of human prion diseases continues to evolve, with some genetic forms progressing slowly over decades, beginning with dysautonomia and neuropathy and progressing to a frontal-executive dementia with pathology of combined prionopathy and tauopathy. Unfortunately, to date, all human prion disease clinical trials have failed to show survival benefit. A very rare polymorphism in the prion protein gene recently has been identified that appears to protect against prion disease; this finding, in addition to providing greater understanding of the prionlike mechanisms of neurodegenerative disorders, might lead to potential treatments.
SUMMARY: Sporadic Jakob-Creutzfeldt disease is the most common form of human prion disease. Genetic prion diseases, resulting from mutations in the prion-related protein gene (PRNP), are classified based on the mutation, clinical phenotype, and neuropathologic features and can be difficult to diagnose because of their varied presentations. Perhaps most relevant to this Continuum issue on neuroinfectious diseases, acquired prion diseases are caused by accidental transmission to humans, but fortunately, they are the least common form and are becoming rarer as awareness of transmission risk has led to implementation of measures to prevent such occurrences.

Entities:  

Mesh:

Year:  2015        PMID: 26633779      PMCID: PMC4879966          DOI: 10.1212/CON.0000000000000251

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  73 in total

1.  The D178N (cis-129M) "fatal familial insomnia" mutation associated with diverse clinicopathologic phenotypes in an Australian kindred.

Authors:  C A McLean; E Storey; R J Gardner; A E Tannenberg; L Cervenáková; P Brown
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

2.  Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Taim Muayqil; Gary Gronseth; Richard Camicioli
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

3.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

Review 4.  Clinical update of Jakob-Creutzfeldt disease.

Authors:  Mee-Ohk Kim; Michael D Geschwind
Journal:  Curr Opin Neurol       Date:  2015-06       Impact factor: 5.710

5.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.

Authors:  P Sanchez-Juan; A Green; A Ladogana; N Cuadrado-Corrales; R Sáanchez-Valle; E Mitrováa; K Stoeck; T Sklaviadis; J Kulczycki; K Hess; M Bodemer; D Slivarichová; A Saiz; M Calero; L Ingrosso; R Knight; A C J W Janssens; C M van Duijn; I Zerr
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

6.  In vivo detection of thalamic gliosis: a pathoradiologic demonstration in familial fatal insomnia.

Authors:  Stéphane Haïk; Damien Galanaud; Marius G Linguraru; Katell Peoc'h; Nicolas Privat; Baptiste A Faucheux; Nicholas Ayache; Jean-Jacques Hauw; Didier Dormont; Jean-Philippe Brandel
Journal:  Arch Neurol       Date:  2008-04

7.  Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic.

Authors:  Matthias Schmitz; Elisabeth Ebert; Katharina Stoeck; André Karch; Steven Collins; Miguel Calero; Theodor Sklaviadis; Jean-Louis Laplanche; Ewa Golanska; Ines Baldeiras; Katsuya Satoh; Raquel Sanchez-Valle; Anna Ladogana; Anders Skinningsrud; Anna-Lena Hammarin; Eva Mitrova; Franc Llorens; Yong Sun Kim; Alison Green; Inga Zerr
Journal:  Mol Neurobiol       Date:  2015-05-07       Impact factor: 5.590

8.  Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.

Authors:  Ignazio Cali; Cathleen J Miller; Joseph E Parisi; Michael D Geschwind; Pierluigi Gambetti; Lawrence B Schonberger
Journal:  Acta Neuropathol Commun       Date:  2015-06-25       Impact factor: 7.801

9.  Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications.

Authors:  Atul Maheshwari; Michael Fischer; Pierluigi Gambetti; Alicia Parker; Aarthi Ram; Claudio Soto; Luis Concha-Marambio; Yvonne Cohen; Ermias D Belay; Ryan A Maddox; Simon Mead; Clay Goodman; Joseph S Kass; Lawrence B Schonberger; Haitham M Hussein
Journal:  Emerg Infect Dis       Date:  2015-05       Impact factor: 6.883

10.  Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey.

Authors:  Jonathan P Clewley; Carole M Kelly; Nick Andrews; Kelly Vogliqi; Gary Mallinson; Maria Kaisar; David A Hilton; James W Ironside; Philip Edwards; Linda M McCardle; Diane L Ritchie; Reza Dabaghian; Helen E Ambrose; O Noel Gill
Journal:  BMJ       Date:  2009-05-21
View more
  52 in total

1.  Precipitous Deterioration of Motor Function, Cognition, and Behavior.

Authors:  Mireya Fernández-Fournier; David C Perry; Maria Carmela Tartaglia; Mary de May; Adam Boxer; Giovanni Coppola; Chadwick W Christine; Eric J Huang; William W Seeley; Bruce L Miller; Steven J DeArmond; Lea T Grinberg; Michael D Geschwind
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

Review 2.  Neuropsychiatric Aspects of Infectious Diseases: An Update.

Authors:  Sahil Munjal; Stephen J Ferrando; Zachary Freyberg
Journal:  Crit Care Clin       Date:  2017-07       Impact factor: 3.598

Review 3.  Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.

Authors:  Chao Peng; Ronald J Gathagan; Virginia M-Y Lee
Journal:  Neurobiol Dis       Date:  2017-07-24       Impact factor: 5.996

Review 4.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

Review 5.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

6.  Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrPSc and Targeting PrPSc for Lysosomal Degradation.

Authors:  Joanna E Pankiewicz; Sandrine Sanchez; Kent Kirshenbaum; Regina B Kascsak; Richard J Kascsak; Martin J Sadowski
Journal:  Mol Neurobiol       Date:  2018-07-09       Impact factor: 5.590

Review 7.  The diagnosis of dementias: a practical tool not to miss rare causes.

Authors:  Camilla Ferrari; Benedetta Nacmias; Sandro Sorbi
Journal:  Neurol Sci       Date:  2017-12-02       Impact factor: 3.307

8.  Tonsillectomy and risk of Parkinson's disease: A danish nationwide population-based cohort study.

Authors:  Elisabeth Svensson; Victor W Henderson; Szimonetta Szépligeti; Morten Gersel Stokholm; Tejs Ehlers Klug; Henrik Toft Sørensen; Per Borghammer
Journal:  Mov Disord       Date:  2017-11-29       Impact factor: 10.338

Review 9.  Rapidly Progressive Dementia.

Authors:  Michael D Geschwind
Journal:  Continuum (Minneap Minn)       Date:  2016-04

10.  Diagnosis of Creutzfeldt-Jakob disease after neurosyphilis: just bad luck or misdiagnosed?

Authors:  Hannelore Liessens; Sophie Lunskens; Regilio Oedit; Erwig Van Buggenhout
Journal:  Acta Neurol Belg       Date:  2021-07-26       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.